2012•Unpublished venueRequires access

Table 75, Strength of evidence for final, intermediate and adverse outcomes comparing injectable low molecular weight heparin prophylaxis to injectable unfractionated heparin prophylaxis in patients who had major orthopedic surgery

Diana M Sobieraj, Craig Ian Coleman, Vanita Tongbram, Soyon Lee, Jennifer A. Colby, Wendy T Chen, Sagar S Makanji, Ajibade O. Ashaye, Jeffrey Kluger, C Michael White

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Heparin, Orthopedic surgery, Low molecular weight heparin, Adverse effect, Surgery, Intensive care medicine, Anesthesia

Back to paper search Browse research topics Original source

Table 75, Strength of evidence for final, intermediate and adverse outcomes comparing injectable low molecular weight heparin prophylaxis to injectable unfractionated heparin prophylaxis in patients who had major orthopedic surgery — Research Paper | ScholarLens